| Boehringer Ingelheim (Schweiz) GmbH - Sifrol 0,125 mg, Tabletten |
| 54277 | | 01 | | Sifrol 0,125 mg | | Tabletten | | N04BC05 | | Pramipexole | | 10.12.1997 | | |
|
| Composition |
| pramipexoli dihydrochloridum monohydricum 0.125 mg corresp. pramipexolum 0.088 mg, mannitolum, maydis amylum, silica colloidalis anhydrica, povidonum K 25, magnesii stearas pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Pramipexol Dihydrochloride Monohydrate | 0.125 mg correspond Pramipexol 0.088 mg |
| | BAG: Active Agent | Dose |
|---|
| Pramipexol Dihydrochloride Monohydrate | 0.125 mg |
| | | | Inactive agents | Dose |
|---|
| Magnesii Stearas pro Compresso | | | Mannitol | | | Maydis Amylum | | | Povidonum K | 25 | | Silica Colloidalis Anhydrica | |
| |
|
| Teilbarkeit |
| | Ja (mit Tablettenteiler) | | | | kA | | | | Ja | | | | -- | | | | | | | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 016 | 30 Tablet(s) | 7.92 | 17.30 | B | SL | Yes |
|
